Testing a new way to find infections in liver disease patients
Part of Digestive system clinical trials.
This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have been diagnosed with cirrhosis (scarring of the liver)
- You currently have a sudden worsening like fluid in the belly, vomiting blood, or confusion from liver problems
- You do not have cancer of the liver or other organs
- You are not taking immune-suppressing medicine for other illnesses
- You do not have HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
This study monitors patients with worsening cirrhosis for certain hard-to-treat bacteria in the gut. It aims to understand how these bacteria spread and how to prevent infections.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This trial tests whether using a sensitive DNA test (mNGS) to find the exact cause of an infection leads to better treatment for liver transplant recipients who got an infection from their donor.
This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
Hear when a new Cirrhosis, Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.